Passa al contenuto
Merck

Shifts in Ribosome Engagement Impact Key Gene Sets in Neurodevelopment and Ubiquitination in Rett Syndrome.

Cell reports (2020-03-27)
Deivid C Rodrigues, Marat Mufteev, Robert J Weatheritt, Ugljesa Djuric, Kevin C H Ha, P Joel Ross, Wei Wei, Alina Piekna, Maria A Sartori, Loryn Byres, Rebecca S F Mok, Kirill Zaslavsky, Peter Pasceri, Phedias Diamandis, Quaid Morris, Benjamin J Blencowe, James Ellis
ABSTRACT

Regulation of translation during human development is poorly understood, and its dysregulation is associated with Rett syndrome (RTT). To discover shifts in mRNA ribosomal engagement (RE) during human neurodevelopment, we use parallel translating ribosome affinity purification sequencing (TRAP-seq) and RNA sequencing (RNA-seq) on control and RTT human induced pluripotent stem cells, neural progenitor cells, and cortical neurons. We find that 30% of transcribed genes are translationally regulated, including key gene sets (neurodevelopment, transcription and translation factors, and glycolysis). Approximately 35% of abundant intergenic long noncoding RNAs (lncRNAs) are ribosome engaged. Neurons translate mRNAs more efficiently and have longer 3' UTRs, and RE correlates with elements for RNA-binding proteins. RTT neurons have reduced global translation and compromised mTOR signaling, and >2,100 genes are translationally dysregulated. NEDD4L E3-ubiquitin ligase is translationally impaired, ubiquitinated protein levels are reduced, and protein targets accumulate in RTT neurons. Overall, the dynamic translatome in neurodevelopment is disturbed in RTT and provides insight into altered ubiquitination that may have therapeutic implications.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Laminina, 1-2 mg/mL in Tris-buffered saline, 0.2 μm filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
Sieroalbumina, heat shock fraction, protease free, fatty acid free, essentially globulin free, pH 7, ≥98%
Sigma-Aldrich
Anticorpo monoclonale ANTI-FLAG® M2, 1 mg/mL, clone M2, affinity isolated antibody, buffered aqueous solution (50% glycerol, 10 mM sodium phosphate, and 150 mM NaCl, pH 7.4)
Sigma-Aldrich
Desossiribonucleasi I, lyophilized powder, Protein ≥85 %, ≥400 Kunitz units/mg protein
Millipore
Gel d′affinità ANTI-FLAG® M2, purified immunoglobulin, buffered aqueous glycerol solution
Sigma-Aldrich
Acido retinoico, ≥98% (HPLC), powder
Sigma-Aldrich
Cocktail di inibitori delle proteasi 2, aqueous solution (dark coloration may develop upon storage, which does not affect the activity)
Sigma-Aldrich
Proteasi, Type XIV, ≥3.5 units/mg solid, powder
Sigma-Aldrich
2′,7′-diclorofluorescina diacetato, ≥97%
Sigma-Aldrich
Serotonina, powder
Sigma-Aldrich
N6,2′-O-Dibutirril-adenosina 3′,5′-ciclica monofosfato, ≥97% (HPLC), powder
Sigma-Aldrich
Gel EMC, liquid, BioReagent, suitable for cell culture
Sigma-Aldrich
Chloroquine diphosphate salt, powder or crystals, 98.5-101.0% (EP)
Sigma-Aldrich
Kynurenic acid, ≥98%
Sigma-Aldrich
Dulbecco′s Modified Eagle′s Medium - low glucose, With 1000 mg/L glucose, and sodium bicarbonate, without L-glutamine, liquid, sterile-filtered, suitable for cell culture
Sigma-Aldrich
Puromicina, ≥98% (HPLC), powder
Sigma-Aldrich
Dorsomorphin, ≥98% (HPLC)
Sigma-Aldrich
Protease Inhibitor Cocktail Set I, A cocktail of five protease inhibitors that will inhibit a broad range of proteases and esterases. Supplied with a data sheet.
Sigma-Aldrich
Collagen solution from bovine skin, Type I, 2.9-3.2 mg/mL, suitable for cell culture, sterile-filtered
Sigma-Aldrich
Acido L-glutammico, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
Strychnine
Sigma-Aldrich
γ-Aminobutyric acid, BioXtra, ≥99%
Sigma-Aldrich
Macrophage Colony-Stimulating Factor human, M-CSF, recombinant, expressed in E. coli, lyophilized powder, suitable for cell culture
Sigma-Aldrich
2-Deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-glucose, ≥97% (HPLC)